Ranolazine Extended-Release Tablets Recalled for Failed Dissolution Specifications
Glenmark Pharmaceuticals is recalling 16,944 bottles of Ranolazine 500mg tablets nationwide due to failed dissolution specifications. Tablets may not dissolve properly, potentially affecting drug efficacy.
- Product
- RANOLAZINE — RANOLAZINE (RANOLAZINE)
- Category
- Drug
- Distribution
- Distributed nationwide